Virios Therapeutics (NASDAQ:VIRI) Stock, Quote.Headers.trade-ideas

Virios Therapeutics

Virios Therapeutics Inc is a development-stage biotechnology company. It is focused advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, such as fibromyalgia ("FM") and Long-COVID ("LC"). Its product candidates includes IMC-1 and IMC-2, IMC-1, is intended to synergistically suppress herpesvirus activation and replication with a more specific activity against the Epstein-Barr virus (herpesvirus HHV-4, IMC-2 is a combination of valacyclovir and celecoxib.

movers image

News

Intraday Update

Markets

Movers

Trading Ideas

APLD

ATPC

AVAH

CMAX

CRWD

DOGZ

EMBC

FTEL

KARO

LGCB

LPSN

MEDS

MEIP

MIRA

MNSO

NCPL

NUKK

NWGL

PRTG

PSIG

RYAAY

SAVA

SERV

SLNA

SLRX

SNOA

SOPA

TELL

TKNO

VIRI

XCUR

Why CrowdStrike Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

Pre-Market Outlook

CISO

NKGN

NUZE

NVOS

ONCO

SDIG

VEEE

Why Tellurian Shares Are Trading Higher By Around 65%; Here Are 20 Stocks Moving Premarket

ADTX

APLM

APVO

AREB

BANL

BYND

CETU

CHUY

LESL

LILM

LTRY

Eaton Vance Massachusetts Municipal Income Trust

SDST

Why Chuy&#39;s Holdings Shares Are Trading Higher By 47%; Here Are 20 Stocks Moving Premarket

Virios Therapeutics Inc

VIRIDIAN THERAPEUTICS ORD

Viridian Therapeutics, Inc. - Common Stock

Viridian Therapeutics Inc

Viridien

Viridien ADR

VIRIDIS MINING & MINERALS by VIRIDIS MINING & MINERALS LTD.

Viridis Mining and Minerals Ltd

XPeng Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>) shares are trading higher<a target="_blank" href="https://www.benzinga.com/premarket" rel="noreferrer noopener"> on Tuesday.</a>
In fact, shares of U.S.-listed Chinese companies are trading higher after <a target="_blank" href="https://www.benzinga.com//node/41004045" rel="noreferrer noopener">China Central Bank announced a new stimulus package.</a>
Xpeng has formed a dealership agreement to penetrate the Qatari market, advancing its global presence, <a target="_blank" href="https://cnevpost.com/2024/09/23/xpeng-signs-dealer-deal-enter-qatar/" rel="noreferrer noopener">reported</a> CnEV Post. The pact designates Pioneer Motors, part of Qatar&#8217;s Almana Group, as its collaborator in this initiative.
According to a <a target="_blank" href="https://www.scmp.com/business/china-business/article/3279572/chinese-ev-maker-xpeng-adds-qatar-export-list-amid-price-war-home" rel="noreferrer noopener">report</a> by the South China Morning Post, by year&#8217;s end, motorists in Qatar will have the opportunity to purchase various all-electric Xpeng models featuring autonomous driving technology, such as the P7 sedan and G6 SUV.
Also Read:<a target="_blank" href="https://www.benzinga.com/markets/equities/24/09/41004167/ready-for-the-road-ford-opens-orders-for-2025-f-series-super-duty-truck" rel="noreferrer noopener"> Ready For The Road &#8211; Ford Opens Orders For 2025 F-Series Super Duty Truck</a>
South China Morning Post added that Latin America, the Middle East, and Southeast Asia are emerging as significant markets for Chinese electric vehicle manufacturers regarding exports and production sites, citing a report published by Moody&#8217;s in late August.
These areas exhibited reduced geopolitical risks, and their electric vehicle adoption is increasing as their gross domestic product per capita rises and their climate change efforts advance, the report noted.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, XPEV stock has lost over 39% in the past year. Investors can gain exposure to the stock via&nbsp;SPDR S&amp;P Kensho Smart Mobility ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HAIL#NYSE">HAIL</a>) and&nbsp;Invesco WilderHill Clean Energy ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBW#NYSE">PBW</a>).
Price Action: XPEV shares are trading higher by 7.17% to $10.25 at last check Tuesday.
Photo via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/40996835" target="_blank" rel="noreferrer noopener">XPeng Touches Production Milestone Of 500K EVs: Here&#8217;s How Many Electric Cars The Chinese Company Has Delivered</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

Media

General

HAIL

LOUP

PowerShares Exchange Traded Fund Trust WilderHill Clean Energy Portfolio

XPEV

What's Going On With XPeng Shares Today?

Telsey Advisory Group analyst Dana Telsey maintains Birkenstock Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BIRK#NYSE">BIRK</a>) with a Outperform and maintains $70 price target.

Price Target

Analyst Ratings

BIRK

Telsey Advisory Group Maintains Outperform on Birkenstock Holding, Maintains $70 Price Target

WIIM

XChange Tec.INC shares are trading higher after the company announced it entered into a securities purchase agreement with VG Master Fund SPC.

Source: <a href="https://www.streetwisereports.com/article/2024/09/20/acquisition-has-other-brazil-lithium-cos-wondering-whos-next.html?utm_medium=feed">Streetwise Reports 09/20/2024</a>
In Brazil&#39;s emerging lithium sector, a US$370 million acquisition of a local company has other junior explorers the wondering if they could be next.
Lithium prices have been on quite the roller coaster. After peaking at a high of over US$79,637 per ton in 2022 on the back of the battery power needed for electric vehicles (EVs) and the energy transition, they hit their lowest point in three years in 2024 after EV sales didn&#39;t soar as high as expected.
But that doesn&#39;t mean lithium won&#39;t still be needed, or that EVs won&#39;t eventually fulfill their promise, helping transition the economy to cleaner energy.
Chief Executive Officer Dale Henderson of Australian miner Pilbara Minerals Ltd. (OTC: <a class="ticker" href="https://www.benzinga.com/stock/pilbf#OTC">PILBF</a>), which recently announced a US$370 million deal to take over Latin Resources Ltd. and its Salinas lithium project in Brazil, said his company is thinking long-term with the purchase.
&quot;The quality of the Salinas project that Latin Resources has developed is very high quality and we think it will be a very low-cost operation once fully developed&quot; Henderson said, according to a Reuters article. &quot;Inevitable price cycles, it will be able to navigate those, we think, with ease.&quot;
Under the all-share deal, Latin Resources shareholders will receive 0.07 new Pilbara shares for each share held. After the deal was announced in August, shares of Latin Resources soared 56% in their biggest one-day percentage gain in more than two years, another Reuters article reported.
In Brazil&#39;s emerging lithium sector, where an &quot;overhaul in lithium export regulations has transformed the country into a burgeoning hub for lithium production&quot; according to S&amp;P Global, the deal has other junior explorers wondering who could be next.
<h2>A New Hub for Lithium Production</h2>
Brazil is becoming a burgeoning hub for lithium production, unlocking vast economic potential and attracting global investments.
&quot;With three operational plants and eight more planned, Brazil&#39;s lithium carbonate equivalent output reached 29,976 Mt (metric tons) in 2023, with expectations of up to a fivefold increase by 2028&quot; S&amp;P noted.
According to BMO Capital Markets analyst Greg Jones in an August 14 research report, the Pilbara acquisition of Latin Resources represented a 32% premium to Latin Resources&#39; 30-day VWAP (volume-weighted average price).
&quot;Based on Latin&#39;s resources of 77.7 Mt at 1.24% Li20, the consideration implies an EV (enterprise value)/resource multiple of ~US$150/t LCE, which is generally in line with multiples paid in other recent lithium developer transactions&quot; Jones wrote.
Latin Resources&#39; &quot;Salinas lithium project has the potential to become one of the 10 largest rock-based lithium operations in the world in terms of production and could open up new growth markets in Europe and North America for Pilbara Minerals&quot; Henderson told the Exposibram (Brazilian International Mining Expo and Congress) event in Brazil, according to an article in Stockhead.
&quot;A September 2023 preliminary economic assessment outlined the potential for an 11-year operation to produce 499,000 tonnes of 5.2% spodumene at total cash costs of US$567 per tonne&quot; at Salinas, Australian mining journalist Kristie Batten wrote for the website. &quot;Capital costs for the two-stage operation are US$308 million, which will be refined by Pilbara as part of an optimized definitive feasibility study by Pilbara once the acquisition closes.&quot;
The deal is expected to close by early December.
<h2>An Opportunity for Buyers</h2>
BMO&#39;s Jones wrote in a late August report that the landscape in the Americas (including South America) is providing an opportunity for buyers, Batten reported.
&quot;Given current valuations and the difficulty in raising capital, we see the conditions as being favorable for M&amp;A from a buyer&#39;s perspective&quot; Jones noted in the report. &quot;In our view, projects that buyers will find the most attractive will offer high-quality resources with large-scale, long-life potential, low capital intensity, operating costs at the lower end of the cost curve, access to infrastructure, as well as benefit from a defined permitting process and social license/community support.&quot;
While the firm sees a &quot;limited universe of potential buyers at the current time&quot; he wrote, &quot;These circumstances could present [an] opportunity for others to outright acquire (e.g., mining-focused private equity), or pursue strategic/joint venture investments (e.g., auto OEMs, battery manufacturers) with less competition.&quot;
&quot;In addition, the current environment may prompt government investment, or direct involvement in order to encourage project development, which could support developer valuations and bridge the gap to a stronger M&amp;A market&quot; Jones wrote, according to Batten.
<h2>The Catalyst: Metal Helps Put Spark in Energy Transition</h2>
What&#39;s the big deal? Lithium is a critical metal vital in the energy transition for its use in batteries for EVs and other applications. It also is used in electronics, medicine and other industries.
Global demand for lithium is expected to maintain the steady climb it commenced in 2020 to at least 2035, Statista data show, reaching 3,829,000 metric tons of LCE from 917,000 metric tons in 2023.
According to a report by Grand View Research, market size for the metal was estimated at US$31.75 billion last year and is projected to grow at a compound annual growth rate (CAGR) of 17.7% from this year through 2030.
&quot;The automotive application segment is expected to witness substantial growth, driven by stringent regulations imposed by government bodies on ICE automakers to reduce carbon dioxide emissions from vehicles&quot; researchers said. &quot;This has shifted the interest of automakers toward producing EVs, which is anticipated to benefit the demand for lithium and related products.&quot;
EVs and battery storage primarily will fuel future growth of the lithium market, Marin Katusa of Katusa Research wrote recently. He pointed out that all major electric vehicle batteries require lithium, about 1.55 pounds per kilowatt hour of battery capacity, on average.
&quot;I think the data speaks for itself that there&#39;s more growth and opportunity on the horizon&quot; Katusa wrote.
<h2>Slowdown Could Easily Reverse</h2>
In a July article for Reuters, Andy Home wrote that the current slowdown could easily reverse.
&quot;One critical facilitator will be the build-out of EV charging infrastructure, a sector which has attracted far less investment than battery manufacturing&quot; he wrote. &quot;Car buyers in Europe and the United States are choosing hybrids because of range anxiety, and they will continue to do so until they see more charging points. The second key factor is price.&quot;
However, &quot;the seeds of the next lithium upswing are already being sown in the current low-price environment&quot; Home wrote.
S&amp;P reported that local industry players in Brazil agree with Pilbara&#39;s Henderson and are confident that &quot;the low-cost structure of their projects and projected competitive production costs will help them withstand the ongoing pricing pressure.&quot;
Following are two junior explorers operating in the country and watching the Pilbara/Latin Resources transaction with deep interest.
<h2>Atlas Lithium Corp.</h2>
Atlas Lithium Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/atlx#NASDAQ">ATLX</a>) announced this year that it has more than doubled its lithium exploration portfolio in the Brazil&#39;s &quot;Lithium Valley&quot; to about 539 square kilometers, or nearly 54,000 hectares (approximately 133,000 acres), leading the company to believe &quot;it has the largest claim ownership position of any listed company in this new lithium frontier&quot; and the &quot;largest lithium exploration footprint in Brazil.&quot;
Earlier this year, Atlas signed an offtake agreement with Mitsui &amp; Co. Ltd. (OTC: <a class="ticker" href="https://www.benzinga.com/stock/mitsf#OTC">MITSF</a>) for future production from the company&#39;s Neves Project. Mitsui is one of the largest global companies with headquarters in Japan; Warren Buffett&#39;s Berkshire Hathaway is one of its largest investors.
Mitsui invested US$30 million in purchasing common shares of Atlas Lithium. In parallel, Mitsui secured an offtake agreement with Atlas Lithium, ensuring access to 15,000 tons of lithium concentrate from the initial production with the potential to expand up to 60,000 tons annually.
The company&#39;s modular dense media separation (DMS) lithium processing plant, fabricated in South Africa and currently in pre-shipment stage, is a key part of its strategy to advance production at its Minas Gerais lithium project in a cost-effective and environmentally sustainable manner.
&quot;Atlas Lithium&#39;s strategic initiatives in Brazil are not just pivotal for the company but also play a crucial role in the broader context of U.S. efforts to reduce dependence on foreign sources for these vital materials&quot; wrote Mangeet Kaur Bouns <a href="https://www.benzinga.com/partner/commodities/24/07/39955895/all-eyes-on-atlas-lithium-as-the-us-assistant-secretary-of-state-for-energy-resources-visits-" rel="noopener" target="_blank">for Benzinga</a>. &quot;The expansion of Atlas Lithium&#39;s exploration footprint in Brazil . . . highlights the potential of this region as a significant contributor to the global supply chain of critical minerals. As the world transitions to a greener energy mix, the demand for these minerals is set to skyrocket.&quot;
And it&#39;s not just for environmental sustainability. The strategic importance of the mineral extends to national security and economic development.
&quot;China&#39;s dominance in producing and processing critical minerals may exacerbate these risks, as highlighted by recent geopolitical tensions and trade restrictions&quot; the Benzinga report said. &quot;To mitigate these vulnerabilities, the U.S. government is focusing on securing supply chains through partnerships and investments in countries rich in critical minerals. With its substantial reserves of copper, lithium, and other critical minerals, Latin America is emerging as a key region for such investments.&quot;
Analyst Joe Reagor of ROTH Capital Partners wrote in a research note on July 26 that &quot;we continue to believe Atlas Lithium Corp. has the potential to enter production in early 2025.&quot;
Heiko Ihle, an analyst with H.C. Wainwright &amp; Co., agreed in a July 9 note.
&quot;We remain confident that the firm can start recording revenue from spodumene at Das Neves once production begins&quot; the analyst wrote.
About 34% of Atlas Lithium is owned by management and insiders. About 11% of the shareholders are institutional, strategic partners with another 12%. The rest, about 43%, is retail.
Top shareholders include Waratah Capital Advisors Ltd. with 4.34%, Mitsui &amp; Co. Ltd. with 12.27%, and Candace Shira Associates LLC with 1.39%, according to Reuters.
Its market cap is about US$143.8 million. It trades in a 52-week range of US$34 and US$8.37.
<h2>Lithium Ionic Corp.</h2>
Another company in the country making the transition from exploration to production is Lithium Ionic Corp. (OTC: <a class="ticker" href="https://www.benzinga.com/stock/lthcf#OTC">LTHCF</a>) has achieved a milestone with the approval of its final exploration reports for the Bandeira and Outro Lado lithium properties by Brazil&#39;s National Mining Agency (Agencia Nacional de Mineracao, or ANM).
The company has submitted both the mining concession application and the economic viability study (Plano de Aproveitamento Economico, or PAE) for its Bandeira property following the ANM&#39;s approval. The PAE outlines technical, economic, and environmental details of the mining project and is seen as essential for securing the final approval needed for the project&#39;s operational phase.
A Feasibility Study published earlier this year for the company&#39;s flagship Bandeira Lithium Project highlighted a post-tax NPV of US$1.31 billion and an IRR of 40% for a 14-year mine life producing an average of 178,000 tonnes per year of 5.5% spodumene concentrate at a low operating cost of US$444 per tonne.
Now, Lithium Ionic is awaiting approval for the Licenca Ambiental Concomitante (LAC), an environmental license that will permit construction at the Bandeira site, with approval expected in the coming months. The LAC is another important step before the mining concession can be fully granted.
In a September 10 research report, BMO&#39;s Jones highlighted the significance of the ANM approval, stating, &quot;LTH has now submitted the Mining Concession application and the Economic Viability Study. Achieving concession status will mark the final legal approval required to transition Bandeira from exploration to extraction/production.&quot;
The analyst maintained an Outperform(S) rating and a target price of CA$2.00 on the stock.
Canaccord Genuity Analyst Katie Lachapelle, in another September 10 research report, wrote that &quot;from a regulatory perspective, the next major hurdle &mdash; and a key catalyst, in our view &mdash; will be the approval of the Licen&ccedil;a Ambiental Concomitante (LAC) for the Bandeira Lithium Project.&quot; Lachapelle maintained her Speculative Buy rating for Lithium Ionic with a price target of CA$2.50.
Finally, Desjardins Analyst Frederic Tremblay rated Lithium Ionic a Buy in an August 15 research note.
Pilbara&#39;s acquisition of Latin Resources reinforces Lithium Ionic&#39;s status as a takeout candidate, Tremblay pointed out. One possibility is that Pilbara acquires Lithium Ionic&#39;s Salinas project, too, given the potential for synergies between it and Latin Resources&#39; Salinas project. Another possibility is that Lithium Ionic gets taken out in its entirety rather than just one of its assets, by a company looking for exposure to Brazil.
&quot;That said, we also continue to view [Lithium Ionic] as an attractive investment even if no takeout scenario ultimately materializes&quot; wrote Tremblay.
According to the company, management and insiders own 20% of the Lithium Ionic.
One of the insiders, President &amp; Director Helio Diniz, owns 5.52%, Director Michael Lawrence Guy owns 5.10%, Director David Patrick Gower owns 2.56%, and Andre Rezende Gumaraes owns 2.52%, according to Reuters.
30% is held by institutional investors. Reuters reports Waratah Captial Advisors owns 7.01%, JGP Gestao de Recursos Ltda owns 2.69%, RBC Global Asset Management Inc owns 1.94%, Sprott Asset Management LP owns 1.55%, BMO Asset Management owns 1.30%, and IXIOS Asset Management SA owns 1.20%. The rest is retail.
Lithium Ionic has 158.58 million shares outstanding and 131.15 million free-float traded shares.
The company&#39;s market cap is CA$104.66 million, and it trades in a 52-week range of CA$0.41 - 2.24 per share.
Important Disclosures:
<ol>
<li>Atlas Lithium Corp. and Lithium Ionic Corp. are billboard sponsors of Streetwise Reports and pay SWR a monthly sponsorship fee between US$4,000 and US$5,000.</li>
<li>Steve Sobek wrote this article for Streetwise Reports LLC and provides services to Streetwise Reports as an employee.</li>
<li>This article does not constitute investment advice and is not a solicitation for any investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Each reader is encouraged to consult with his or her personal financial adviser and perform their own comprehensive investment research. By opening this page, each reader accepts and agrees to Streetwise Reports&#39; terms of use and full legal disclaimer. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company.</li>
</ol>

Government

Latin America

Mid Cap

Penny Stocks

Regulations

Small Cap

Legal

Management

ATLX

LTHCF

MITSF

PILBF

Acquisition Has Other Brazil Lithium Cos. Wondering Who's Next

TD Cowen analyst Robert Moskow maintains Lamb Weston Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LW#NYSE">LW</a>) with a Hold and raises the price target from $61 to $65.

TD Cowen Maintains Hold on Lamb Weston Hldgs, Raises Price Target to $65

Goldman Sachs analyst Christine Cho maintains McDonald's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) with a Neutral and raises the price target from $284 to $325.

Goldman Sachs Maintains Neutral on McDonald's, Raises Price Target to $325

Pseudonymous crypto trader Dentoshi thinks the performance of meme coins Dogwifhat (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">WIF</a>) and Pepe (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">PEPE</a>) could signal the continuation or end of the current &#8220;<a href="https://www.benzinga.com/markets/cryptocurrency/24/06/39420068/is-the-meme-coin-super-cycle-over-trader-outlines-pros-and-cons">memecoin supercycle</a>.&#8221;
What Happened: Dentoshi, known for his technical analysis, took to his social media <a href="https://x.com/Dentoshi/status/1838521939758928027">account</a> to analyze the situation of the two popular meme coins.
A strong reaction off the 0.382 Fibonacci level for WIF could indicate a direct continuation of the uptrend. Dentoshi reminds reader that the meme coin attempted this in May, stating, "We tried in May with WIF, pumped 30% higher from entry but wasn&#8217;t able to sustain."
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="531" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/24102436/image-191-1024x531.png" alt="" class="wp-image-563388" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/24102436/image-191-1024x531.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/24102436/image-191-300x155.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/24102436/image-191-768x398.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/24102436/image-191-1536x796.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/24102436/image-191.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
The second scenario, which Dentoshi seems to view as more critical at this juncture, involves a deeper retracement into the 0.618 to 0.707 Fibonacci zone. He suggests that if the market still has momentum, this should represent the lowest point of the pullback before a potential upward move.
The trader emphasizes the importance of confirmation before entering a position, advising traders to get involved only after seeing a clear breakout from this area.
For the unfamiliar, Fibonacci retracement levels are&nbsp;horizontal lines on a chart that indicate potential support and resistance levels for a meme coin.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/digital-assets/ "><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/27091545/Benzinga-conference.gif" alt="Benzinga future of digital assets conference" class="wp-image-267246" /></a></figure>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40956111/pepe-leapfrogs-dogecoin-shiba-inu-in-30-day-gains-trading-volume-no-one-is-bullish-enough-">Pepe Leapfrogs Dogecoin, Shiba Inu In 30-Day Gains, Trading Volume: &#8216;No One Is Bullish Enough,&#8217; Says Trader</a>
Why It Matters: The trader&#8217;s analysis implies that the current price action of WIF and PEPE could be at a pivotal point.
If these meme coins show strength and bounce from these deeper Fibonacci levels, it might signal a continuation of the broader meme coin trend and possibly influence the overall crypto market sentiment.
Dogwifhat and Pepe individually and combined have higher trading volumes in the past 24 hours in comparison to Dogecoin and Shiba Inu. Total meme coin market capitalization currently stands at $46.3 billion, a 4.1% increase in the past 24 hours.
What&#8217;s Next: The influence of&nbsp;<a href="https://www.benzinga.com/money/is-bitcoin-a-good-investment" target="_blank" rel="noreferrer noopener">Bitcoin as an institutional asset class</a>&nbsp;is expected to be thoroughly explored at Benzinga&#8217;s upcoming&nbsp;<a href="https://www.benzinga.com/events/digital-assets/agenda/" target="_blank" rel="noreferrer noopener">Future of Digital Assets</a>&nbsp;event on Nov. 19.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40941388/shiba-inu-killer-dogwifhat-erupts-for-17-gain-will-erase-six-months-of-downtrend-in-2-3-we">&#8216;Shiba Inu Killer&#8217; Dogwifhat Erupts For 17% Gain, Will Erase &#8216;Six Months Of Downtrend In 2-3 Weeks,&#8217; According To Trader</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$PEPE

$WIF

These 2 Meme Coins Will Show Us If The 'Mania' Continues, Says Trader: But It's Neither DOGE Nor SHIB

<a href="https://www.youtube.com/watch?v=ZFW3ONApp4w" title="https://www.youtube.com/watch?v=ZFW3ONApp4w">https://www.youtube.com/watch?v=ZFW3ONApp4w</a>

Macro Notification

GOOG

GOOGL

INTC

MSFT

NVDA

Biden Says Global Rules Needed For Artificial Intelligence; As AI Grows More Powerful, It Must Grow Responsive To Our Collective Values

Macro Economic Events

Market Summary

Economics

Benzinga Market Summary: Biden Addresses AI And Foreign Policy At UN, Oil Rises On China Stimulus And Middle East Tensions, S&P Falls On Weak Consumer Confidence Data

Goldman Sachs analyst Michael Ng maintains F5 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIV#NASDAQ">FFIV</a>) with a Neutral and raises the price target from $185 to $212.

FFIV

Goldman Sachs Maintains Neutral on F5, Raises Price Target to $212

Global

MELI

MercadoLibre To More Than Double Brazil Distribution Centers

Goldman Sachs analyst Bruno Amorim maintains Ecopetrol (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EC#NYSE">EC</a>) with a Neutral and lowers the price target from $11 to $9.5.

Goldman Sachs Maintains Neutral on Ecopetrol, Lowers Price Target to $9.5

Rosenblatt analyst Barton Crockett maintains Quad/Graphics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QUAD#NYSE">QUAD</a>) with a Buy and maintains $7.6 price target.

QUAD

Rosenblatt Maintains Buy on Quad/Graphics, Maintains $7.6 Price Target

AEMD

APDN

CMRX

GOVX

MRNA

TNXP

VRAX

Biden On Sudan Says End This War Now; Let's Move Quickly To Face Mpox Outbreak In Africa

Deep-pocketed investors have adopted a bearish approach towards ASML Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NASDAQ">ASML</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in ASML usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 21 extraordinary options activities for ASML Holding. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 33% leaning bullish and 47% bearish. Among these notable options, 5 are puts, totaling $241,150, and 16 are calls, amounting to $878,325.
<h3>Expected Price Movements</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $420.0 to $1060.0 for ASML Holding over the last 3 months. 
<h3>Insights into Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for ASML Holding options trades today is 72.16 with a total volume of 147.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for ASML Holding's big money trades within a strike price range of $420.0 to $1060.0 over the last 30 days.
<h3>ASML Holding 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727188258_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ASML</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$38.3</td>
<td>$35.0</td>
<td>$38.3</td>
<td>$805.00</td>
<td>$157.0K</td>
<td style="text-align: right;">41</td>
<td style="text-align: right;">42</td>
</tr>
<tr>
<td>ASML</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$66.4</td>
<td>$65.2</td>
<td>$66.4</td>
<td>$865.00</td>
<td>$99.6K</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">15</td>
</tr>
<tr>
<td>ASML</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$57.5</td>
<td>$56.7</td>
<td>$56.7</td>
<td>$880.00</td>
<td>$90.7K</td>
<td style="text-align: right;">53</td>
<td style="text-align: right;">17</td>
</tr>
<tr>
<td>ASML</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$52.7</td>
<td>$52.3</td>
<td>$52.7</td>
<td>$780.00</td>
<td>$63.2K</td>
<td style="text-align: right;">44</td>
<td style="text-align: right;">14</td>
</tr>
<tr>
<td>ASML</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$34.5</td>
<td>$33.7</td>
<td>$33.7</td>
<td>$820.00</td>
<td>$53.9K</td>
<td style="text-align: right;">107</td>
<td style="text-align: right;">16</td>
</tr>
</tbody>
</table>

<h3>About ASML Holding</h3>
ASML is the leader in photolithography systems used in the manufacturing of semiconductors. Photolithography is the process in which a light source is used to expose circuit patterns from a photo mask onto a semiconductor wafer. The latest technological advances in this segment allow chipmakers to continually increase the number of transistors on the same area of silicon, with lithography historically representing a high portion of the cost of making cutting-edge chips. ASML outsources the manufacturing of most of its parts, acting like an assembler. ASML's main clients are TSMC, Samsung, and Intel.
Following our analysis of the options activities associated with ASML Holding, we pivot to a closer look at the company's own performance.
<h3>ASML Holding's Current Market Status</h3>
<ul>
<li>Trading volume stands at 180,205, with ASML's price up by 0.47%, positioned at $807.24.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 22 days.</li>
</ul>
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest ASML Holding options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

ASML

Looking At ASML Holding's Recent Unusual Options Activity

Financial giants have made a conspicuous bullish move on Nike. Our analysis of options history for Nike (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) revealed 9 unusual trades.
Delving into the details, we found 66% of traders were bullish, while 33% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $156,820, and 6 were calls, valued at $328,609.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $79.0 and $120.0 for Nike, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for Nike options trades today is 1770.67 with a total volume of 4,277.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Nike's big money trades within a strike price range of $79.0 to $120.0 over the last 30 days.
<h3>Nike Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727188252_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NKE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/27/24</td>
<td>$0.63</td>
<td>$0.62</td>
<td>$0.64</td>
<td>$88.00</td>
<td>$126.8K</td>
<td>3.4K</td>
<td>3.5K</td>
</tr>
<tr>
<td>NKE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/18/26</td>
<td>$27.45</td>
<td>$25.65</td>
<td>$27.5</td>
<td>$110.00</td>
<td>$68.7K</td>
<td>95</td>
<td>25</td>
</tr>
<tr>
<td>NKE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/27/24</td>
<td>$3.2</td>
<td>$3.05</td>
<td>$3.2</td>
<td>$85.00</td>
<td>$64.0K</td>
<td>2.3K</td>
<td>519</td>
</tr>
<tr>
<td>NKE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$13.8</td>
<td>$13.7</td>
<td>$13.8</td>
<td>$100.00</td>
<td>$53.8K</td>
<td>907</td>
<td>90</td>
</tr>
<tr>
<td>NKE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>10/11/24</td>
<td>$9.7</td>
<td>$9.6</td>
<td>$9.7</td>
<td>$79.00</td>
<td>$38.8K</td>
<td>913</td>
<td>41</td>
</tr>
</tbody>
</table>

<h3>About Nike</h3>
Nike is the largest athletic footwear and apparel brand in the world. Key categories include basketball, running, and football (soccer). Footwear generates about two thirds of its sales. Its brands include Nike, Jordan (premium athletic footwear and clothing), and Converse (casual footwear). Nike sells products worldwide through company-owned stores, franchised stores, and third-party retailers. The firm also operates e-commerce platforms in more than 40 countries. Nearly all its production is outsourced to contract manufacturers in more than 30 countries. Nike was founded in 1964 and is based in Beaverton, Oregon.
<h3>Where Is Nike Standing Right Now?</h3>
<ul>
<li>With a trading volume of 3,836,512, the price of NKE is up by 1.95%, reaching $87.88.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 7 days from now.</li>
</ul>
<h3>Expert Opinions on Nike</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $88.4.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Morgan Stanley has decided to maintain their Equal-Weight rating on Nike, which currently sits at a price target of $79. 
&#x2A; An analyst from Wells Fargo has decided to maintain their Overweight rating on Nike, which currently sits at a price target of $95. 
&#x2A; An analyst from B of A Securities downgraded its action to Buy with a price target of $104. 
&#x2A; An analyst from Barclays persists with their Equal-Weight rating on Nike, maintaining a target price of $84. 
&#x2A; An analyst from Piper Sandler has revised its rating downward to Neutral, adjusting the price target to $80. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Nike with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Decoding Nike's Options Activity: What's the Big Picture?

Investors with a lot of money to spend have taken a bearish stance on Boeing (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with BA, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 29 uncommon options trades for Boeing.
This isn't normal.
The overall sentiment of these big-money traders is split between 27% bullish and 65%, bearish.
Out of all of the special options we uncovered, 16 are puts, for a total amount of $1,481,420, and 13 are calls, for a total amount of $604,266.
<h3>Expected Price Movements</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $100.0 to $180.0 for Boeing over the recent three months. 
<h3>Volume &amp; Open Interest Trends</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Boeing's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Boeing's whale activity within a strike price range from $100.0 to $180.0 in the last 30 days. 
<h3>Boeing 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727188247_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>BA</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$6.7</td>
<td>$6.6</td>
<td>$6.61</td>
<td>$150.00</td>
<td>$198.3K</td>
<td>8.5K</td>
<td>2.6K</td>
</tr>
<tr>
<td>BA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$6.55</td>
<td>$6.5</td>
<td>$6.55</td>
<td>$150.00</td>
<td>$158.5K</td>
<td>8.5K</td>
<td>1.9K</td>
</tr>
<tr>
<td>BA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$6.75</td>
<td>$6.7</td>
<td>$6.75</td>
<td>$150.00</td>
<td>$135.6K</td>
<td>8.5K</td>
<td>4.3K</td>
</tr>
<tr>
<td>BA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$6.65</td>
<td>$6.6</td>
<td>$6.65</td>
<td>$150.00</td>
<td>$133.0K</td>
<td>8.5K</td>
<td>3.7K</td>
</tr>
<tr>
<td>BA</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$6.6</td>
<td>$6.45</td>
<td>$6.51</td>
<td>$150.00</td>
<td>$130.2K</td>
<td>8.5K</td>
<td>214</td>
</tr>
</tbody>
</table>

<h3>About Boeing</h3>
Boeing is a major aerospace and defense firm. It operates in three segments: commercial airplanes; defense, space, and security; and Global services. Boeing's commercial airplanes segment competes with Airbus in the production of aircraft that can carry more than 130 passengers. Boeing's defense, space, and security segment competes with Lockheed, Northrop, and several other firms to create military aircraft, satellites, and weaponry. Global services provides aftermarket support to airlines.
Having examined the options trading patterns of Boeing, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Current Position of Boeing</h3>
<ul>
<li>With a volume of 1,572,830, the price of BA is down -0.99% at $154.75. </li>
<li>RSI indicators hint that the underlying stock may be approaching oversold.</li>
<li>Next earnings are expected to be released in 29 days.</li>
</ul>
<h3>What Analysts Are Saying About Boeing</h3>
Over the past month, 3 industry analysts have shared their insights on this stock, proposing an average target price of $187.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Jefferies persists with their Buy rating on Boeing, maintaining a target price of $240. 
&#x2A; An analyst from Wells Fargo downgraded its action to Underweight with a price target of $119. 
&#x2A; An analyst from Goldman Sachs has decided to maintain their Buy rating on Boeing, which currently sits at a price target of $202. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Boeing options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Boeing Unusual Options Activity

Datadog (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DDOG#NASDAQ">DDOG</a>) has outperformed the market over the past 5 years by 14.0% on an annualized basis producing an average annual return of 27.88%. Currently, Datadog has a market capitalization of $39.10 billion. 
Buying $1000 In DDOG: If an investor had bought $1000 of DDOG stock 5 years ago, it would be worth $3,593.74 today based on a price of $115.97 for DDOG at the time of writing.
<h3>Datadog's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727188216_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

DDOG

$1000 Invested In This Stock 5 Years Ago Would Be Worth $3,600 Today

Fabrinet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FN#NYSE">FN</a>) has outperformed the market over the past 10 years by 20.67% on an annualized basis producing an average annual return of 31.84%. Currently, Fabrinet has a market capitalization of $8.39 billion. 
Buying $100 In FN: If an investor had bought $100 of FN stock 10 years ago, it would be worth $1,570.92 today based on a price of $232.06 for FN at the time of writing.
<h3>Fabrinet's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727188211_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In Fabrinet 10 Years Ago Would Be Worth This Much Today

Alliance Global Partners analyst Scott Henry initiates coverage on Lipocine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LPCN#NASDAQ">LPCN</a>) with a Buy rating and announces Price Target of $10.

Initiation

LPCN

Alliance Global Partners Initiates Coverage On Lipocine with Buy Rating, Announces Price Target of $10

Virios Therapeutics shares slid on pricing public offering of units to raise $1.7M

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are a great way to start the trading week and we have all of the hottest news worth reading about on Monday!



Moving stocks this morning are ongoing meme trading, earnings reports, a reverse stock split and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>MultiMetaVerse (NASDAQ:<a href="https://investorplace.com/stock-quotes/mmv-stock-quote/">MMV</a>) stock is rocketing more than 118% alongside heavy pre-market trading.</li>



<li>GT Biopharma (NASDAQ:<a href="https://investorplace.com/stock-quotes/gtbp-stock-quote/">GTBP</a>) shares are soaring over 88% with strong early morning trading.</li>



<li>Faraday Future (NASDAQ:<a href="https://investorplace.com/stock-quotes/ffie-stock-quote/">FFIE</a>) stock is surging more than 81% after <a href="https://www.nasdaq.com/press-release/faraday-future-announces-fourth-quarter-and-full-year-2023-earnings-webcast-timing">announcing the date</a> for its next earnings report.</li>



<li>Tantech (NASDAQ:<a href="https://investorplace.com/stock-quotes/tanh-stock-quote/">TANH</a>) shares are gaining over 52% with heavy trading this morning.</li>



<li>Shineco (NASDAQ:<a href="https://investorplace.com/stock-quotes/sisi-stock-quote/">SISI</a>) stock is rising more than 31% with heavy trading on Monday morning.</li>



<li>Kintara Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/ktra-stock-quote/">KTRA</a>) shares are increasing over 28% with strong early morning trading.</li>



<li>Dyne Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/dyn-stock-quote/">DYN</a>) stock is climbing more than 27% alongside <a href="https://www.nasdaq.com/press-release/dyne-therapeutics-announces-new-clinical-data-from-achieve-trial-of-dyne-101-in-dm1">new clinical trial data</a>.</li>



<li>Sintx Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/sint-stock-quote/">SINT</a>) shares are heading over 24% higher with extremely heavy trading this morning.</li>



<li>Crown ElectroKinetics (NASDAQ:<a href="https://investorplace.com/stock-quotes/crkn-stock-quote/">CRKN</a>) stock is jumping more than 22% as <a href="https://www.marketwatch.com/story/crown-electrokinetics-meme-stock-rockets-again-on-massive-volume-7aad90cd">meme trading of the shares continues</a>.</li>



<li>Cue Health (NASDAQ:<a href="https://investorplace.com/stock-quotes/hlth-stock-quote/">HLTH</a>) shares are up close to 21% with heavy trading today.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Essa Pharma (NASDAQ:<a href="https://investorplace.com/stock-quotes/epix-stock-quote/">EPIX</a>) stock is crashing 60% without any clear news.</li>



<li>Virios Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/viri-stock-quote/">VIRI</a>) shares are plummeting nearly 44% after <a href="https://www.nasdaq.com/press-release/virios-therapeutics-announces-pricing-of-%241.7-million-public-offering-of-common-stock">pricing a public offering</a>.</li>



<li>Jaguar Health (NASDAQ:<a href="https://investorplace.com/stock-quotes/jagx-stock-quote/">JAGX</a>) stock is diving over 37% as it prepares for a <a href="https://www.nasdaq.com/press-release/jaguar-health-inc.-announces-reverse-stock-split-2024-05-17">reverse stock split</a>.</li>



<li>Jeffs Brands (NASDAQ:<a href="https://investorplace.com/stock-quotes/jfbr-stock-quote/">JFBR</a>) shares are tumbling more than 28% on Monday morning.</li>



<li>FLJ Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/flj-stock-quote/">FLJ</a>) stock is taking an over 27% beating despite a lack of news today.</li>



<li>Akanda (NASDAQ:<a href="https://investorplace.com/stock-quotes/akan-stock-quote/">AKAN</a>) shares are sliding more than 22% after announcing a <a href="https://finance.yahoo.com/news/akanda-corp-announces-registered-direct-142600060.html">registered direct offering</a>.</li>



<li>Barnes &amp; Noble Education (NYSE:<a href="https://investorplace.com/stock-quotes/bned-stock-quote/">BNED</a>) stock is dropping over 17% today.</li>



<li>ATRenew (NYSE:<a href="https://investorplace.com/stock-quotes/rere-stock-quote/">RERE</a>) shares are falling more than 15% alongside its <a href="https://www.nasdaq.com/press-release/atrenew-inc.-reports-unaudited-first-quarter-2024-financial-results-2024-05-20">Q1 2024 earnings</a>.</li>



<li>Syra Health (NASDAQ:<a href="https://investorplace.com/stock-quotes/syra-stock-quote/">SYRA</a>) stock is decreasing over 14% today.</li>



<li>Xinyuan Real Estate (NYSE:<a href="https://investorplace.com/stock-quotes/xin-stock-quote/">XIN</a>) shares close out our pre-market stock movers down more than 12% this morning.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/05/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-may-20th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Virios Therapeutics&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/viri-stock-quote/">VIRI</a>) stock is falling on Monday after the development-stage biotechnology company announced the <a href="https://www.nasdaq.com/press-release/virios-therapeutics-announces-pricing-of-%241.7-million-public-offering-of-common-stock">pricing of a public offering</a> for its shares.



Virios Therapeutics is selling 8.5 million shares of VIRI stock at a price of 20 cents per share. This has the company expecting gross proceeds of $1.7 million from this public offering.



Virios Therapeutics intends to use the funds from this offering for its IMC-2 Long-COVID Phase 2b study. The money will also be used for general corporate purposes. Investors will also note that the sole placement agent for the offering is Maxim Group LLC.



<h2>What This Means for VIRI Stock</h2>



A public stock offering increases the total number of VIRI shares on the market. Doing this dilutes the stakes of current shareholders in the company. That&rsquo;s one reason why VIRI stock is down today.



The other has to do with the pricing of the offering. At 20 cents per share, this is a significant discount from its prior closing price of 35 cents. That&rsquo;s another negative dragging down the price of the stock this morning.



VIRI stock is down 43.8% as of Monday morning. The stock was also down 39.4% year-to-date when markets last closed.



Investors seeking out more of the latest stock market stories are in luck!



We have all of the hottest stock market news ready to go on Monday! A few examples include what&rsquo;s happening with shares of GT Biopharma&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/gtbp-stock-quote/">GTBP</a>)&nbsp;stock, MultiMetaVerse&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/mmv-stock-quote/">MMV</a>) stock and the biggest pre-market stock movers this morning. That news is good to go at the links below!



<h2>More Monday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/05/why-is-gt-biopharma-gtbp-stock-up-143-today/">Why Is GT Biopharma (GTBP) Stock Up 143% Today?</a></li>



<li><a href="https://investorplace.com/2024/05/why-is-multimetaverse-mmv-stock-up-105-today/">Why Is MultiMetaVerse (MMV) Stock Up 105% Today?</a></li>



<li><a href="https://investorplace.com/2024/05/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-may-20th/">Today&rsquo;s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on&nbsp;Monday</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/05/why-is-virios-therapeutics-viri-stock-down-44-today/">Why Is Virios Therapeutics (VIRI) Stock Down 44% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Virios Therapeutics (VIRI) Stock Down 44% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Jaguar Health&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/jagx-stock-quote/">JAGX</a>) stock is falling on Monday as the company prepares for a <a href="https://www.nasdaq.com/press-release/jaguar-health-inc.-announces-reverse-stock-split-2024-05-17">reverse stock split later this week</a>.



Jaguar Health is going to enact a one-for-60 reverse stock split on Thursday. That will see it consolidate 60 shares of JAGX stock into a single share. This will have the shares start trading on a split-adjusted basis when markets open that day.



Jaguar Health notes that its shares will continue to trade on the Nasdaq Capital Market under the JAGX ticker post-split. However, the shares will be using 47010C805 as the new CUSIP number after the split.



<h2>What&rsquo;s Behind the JAGX Reverse Stock Split?</h2>



Jaguar Health is undergoing a reverse stock split to boost the price of its shares. The company is doing this to regain compliance with the minimum bid price rule for the exchange.



Jaguar Health also notes that it expects extra benefits from this reverse stock split. It believes it will alter the share price and total outstanding shares in a way that will make the company more attractive to institutional investors.



JAGX stock is down 40.3% as of Monday morning.



There are plenty more stock market stories that traders will want to read about on today. That includes everything happening with shares of Virios Therapeutics&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/viri-stock-quote/">VIRI</a>), GT Biopharma&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/gtbp-stock-quote/">GTBP</a>) and MultiMetaVerse&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/mmv-stock-quote/">MMV</a>) stock today. All of this news is available below!



<h2>More Stock Market News for Monday</h2>



<ul><li><a href="https://investorplace.com/2024/05/why-is-virios-therapeutics-viri-stock-down-44-today/">Why Is Virios Therapeutics (VIRI) Stock Down 44% Today?</a></li>



<li><a href="https://investorplace.com/2024/05/why-is-gt-biopharma-gtbp-stock-up-143-today/">Why Is GT Biopharma (GTBP) Stock Up 143% Today?</a></li>



<li><a href="https://investorplace.com/2024/05/why-is-multimetaverse-mmv-stock-up-105-today/">Why Is MultiMetaVerse (MMV) Stock Up 105% Today?</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/05/why-is-jaguar-health-jagx-stock-down-40-today/">Why Is Jaguar Health (JAGX) Stock Down 40% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Jaguar Health (JAGX) Stock Down 40% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Red Lobster bankruptcy is a hot topic among traders on Monday after the popular seafood chain submitted a voluntary filing this morning.



Red Lobster has announced that it will <a href="https://www.prnewswire.com/news-releases/red-lobster-files-voluntary-chapter-11-petitions-to-strengthen-financial-position-and-maximize-value-for-stakeholders-302149769.html">enter Chapter 11 bankruptcy protection</a> as it works to reduce operating expenses. The company is also looking to reduce its number of locations and pursue a sale of all of its assets as a going concern.



Red Lobster intends to keep its restaurants open throughout the bankruptcy. The company notes that it has already obtained a $100 million&nbsp;debtor-in-possession financing agreement from existing lenders to allow this.



Red Lobster CEO Jonathan Tibus said the following about the bankruptcy.




&ldquo;This restructuring is the best path forward for Red Lobster. It allows us to address several financial and operational challenges and emerge stronger and re-focused on our growth. The support we&rsquo;ve received from our lenders and vendors will help ensure that we can complete the sale process quickly and efficiently while remaining focused on our employees and guests.&rdquo;




<h2>Red Lobster Bankruptcy: Locations Closing</h2>



Red Lobster <a href="https://investorplace.com/2024/05/red-lobster-closures-2024-is-your-favorite-restaurant-closing/">closures started last week</a> ahead of the company&rsquo;s bankruptcy filing. That saw the company shutter dozens of stores across the U.S. The company started this while searching for a buyer. It&rsquo;s also been dealing with increased inflation changing consumer habits, higher lease prices as well as increasing labor wages.



Investors will find more of the most recent stock market stories below!



We have all of the latest market happenings worth reading about on Monday! Among that is what has shares of Nvidia&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/nvda-stock-quote/">NVDA</a>), Jaguar Health&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/jagx-stock-quote/">JAGX</a>) and Virios Therapeutics&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/viri-stock-quote/">VIRI</a>) stock moving today. All of that news is available below!



<h2>More Monday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/05/nvidia-earnings-forecast-what-nvda-stock-investors-can-expect-on-may-22/">Nvidia Earnings Forecast: What NVDA Stock Investors Can Expect on May 22</a></li>



<li><a href="https://investorplace.com/2024/05/why-is-jaguar-health-jagx-stock-down-40-today/">Why Is Jaguar Health (JAGX) Stock Down 40% Today?</a></li>



<li><a href="https://investorplace.com/2024/05/why-is-virios-therapeutics-viri-stock-down-44-today/">Why Is Virios Therapeutics (VIRI) Stock Down 44% Today?</a></li>
</ul>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/05/red-lobster-bankruptcy-what-happened-to-the-popular-seafood-chain/">Red Lobster Bankruptcy: What Happened to the Popular Seafood Chain?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Red Lobster Bankruptcy: What Happened to the Popular Seafood Chain?

Analyst Jason McCarthy of Maxim Group reiterated a Buy rating on Virios Therapeutics (VIRI – Research Report), retaining the price target of $1.00....

Optimistic Buy Rating for Virios Therapeutics as IMC-2 Advances in Clinical Trials with Promising Phase 2 Results

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Virios Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/viri-stock-quote/">VIRI</a>) just reported results for the second quarter of 2024.<ul><li>Virios Therapeutics reported earnings per share of -5 cents. This was above the analyst estimate for EPS of -6 cents.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/viri-stock-earnings-virios-therapeutics-for-q2-of-2024/">VIRI Stock Earnings: Virios Therapeutics Beats EPS for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

VIRI Stock Earnings: Virios Therapeutics Beats EPS for Q2 2024

Analyst Sean Lee CFA from H.C. Wainwright maintained a Hold rating on Virios Therapeutics (VIRI – Research Report) and decreased the price target t...

Hold Rating Maintained for Virios Therapeutics Amidst Financial Uncertainty and Pipeline Prospects

Virios Therapeutics reports Q2 results

In a report released yesterday, Jason McCarthy from Maxim Group maintained a Buy rating on Virios Therapeutics (VIRI – Research Report), with a pri...

Buy Rating for Virios Therapeutics Amid Promising Long COVID Treatment and Legislative Tailwinds

AKAN

BNED

CRKN

EPIX

FFIE

GTBP

HLTH

JAGX

JFBR

KTRA

RERE

SINT

SISI

SYRA

TANH

Earnings

Press Releases

Virios Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results

Health Care

Virios Therapeutics Announces Publication of International Patent for IMC-2 Covering Antiviral Treatment of Long-COVID

Virios Therapeutics to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024

Virios Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Virios Therapeutics

Virios Therapeutics (VIRI) Forecast

Virios Therapeutics (NASDAQ:VIRI) Stock, Quote.Headers.trade-ideas